Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1747-1751

  Ohashi, Kazuo ^a   Tsutsumi, Masahiro ^a   Nakajima, Yoshiyuki ^a   Kobitsu, Kunihiko ^a   Nakano, Hiroshige ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

adenomatous hyperplasia of the liver; hepatitis virus infection; hepatocellular carcinoma; liver cirrhosis; telomere

Indexed keywords

DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; CELL DIVISION; CONFERENCE PAPER; CONTROLLED STUDY; HEPATITIS; HEPATITIS VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT; TELOMERE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HEPATITIS C; HUMANS; LIVER; LIVER NEOPLASMS; MIDDLE AGED; TELOMERE;

EID: 0029939998     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1747::AID-CNCR50>3.0.CO;2-W     Document Type: Conference Paper

References (28)

1. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6.
2. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
3. Meltzer PS, Guan X-Y, Trent JM. Telomere capture stabilizes chromosome breakage. Nat Genet 1993;4:252-5.
4. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-60.
5. Hastie ND, Dempster M, Dunlop MG, Thompsom AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-8.
6. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell ageing. J Mol Biol 1992;225:951-60.
7. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-82.
8. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-8.
9. Counter CM, Avilion AA, Lefeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability of arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
10. Beasley RP. Hepatitis B virus as etiologic agent in hepatocellular carcinoma: epidemiologic consideration. Hepatology 1982;2:21-6.
11. Hasan F, Jeffers LJ, Medina MD, Reddy KR, Parker T, Schiff ER, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990;12:589-91.
12. Kim CM, Koike K, Saito I, Miyamura T, Jay G. The HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317-20.
13. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990;343:555-7.
14. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-Hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994;54:3171-2.
15. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991;51: 5520-5.
16. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 1994;54:231-5.
17. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984;81:1991-5.
18. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 1954;7:462-503.
19. Mehle C, Ljungberg B, Roos G. Telomere shortening in renal cell carcinoma. Cancer Res 1994;54:236-41.
20. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
21. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
22. Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple grade in single HCC. Liver 1987;7:18-26.
23. Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M. Adenomatous hyperplasia in the vincinity of small hepatocellular carcinoma. Hepatology 1992;15:843-8.
24. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-6.
25. Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK. Restoration of telomerase in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 1994;14:961-9.
26. Farber E. Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes Memorial Lecture. Cancer Res 1984;44:5463-74.
27. Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 1994;73:1149-54.
28. Kastan MB, Kuerbitz SJ. Control of G1 arrest after DNA damage. Environ Health Perspect 1993;101:55-8.